About Roche Diagnostics Middle East

We place the patient's needs first and are committed to innovation and excellence. We empower better medical decision-making with leading In-Vitro Diagnostics, know-how, services, and digital solutions. As advocates of ethical business, we work as one team. Together and in partnership with healthcare providers, we aspire to be closer to patients. We are Roche Diagnostics Middle East.

In 2012, Roche have taken the unprecedented move of being the first IVD company to have a Management Centre in the Middle East. This base of operations reinforces the commitment to global Roche standards and is driven by a full team of vastly experienced specialists offering a complete portfolio of services. With this regional empowerment, Roche has moved its leadership and decision-making closer to its customers and distributors. These investments allow Roche Diagnostics Middle East to become the preferred IVD partner.

Early accurate diagnosis is essential to maintain health, prevent disease, find treatments and potential cures. With our innovations and profound commitment to make a lasting impact on society we will improve the standard of care for humankind. With the passion to make a difference we tackle the challenges of today as we anticipate the needs of tomorrow. Improving the lives of billions of people across the globe is what drives us.

The Value of In Vitro Diagnostics

The practice of medicine remains an art, but it’s science that drives the decisions doctors make. And the science never stops. Every day, medical research adds more information to the global knowledge base about the causes of disease, treatment options, and the ways patients respond.

That’s the challenge healthcare faces – how to take this boundless and complex amount of information and glean the essential insights to make the right decision at the right time. Fortunately, advanced diagnostics and aggregated healthcare data are helping turn that complexity into certainty, benefiting doctors, patients, and healthcare systems around the world.

The power of three: automation, digitalization, and integration are taking diagnostics beyond the lab and beyond what laboratory scientists would have believed possible just a few years ago. With the Integrated Core Lab (ICL), we are vastly expanding the efficiency, scope and quality of diagnostic capabilities.

With automation and digitalization, medical technologies and information systems can “talk” to each other in standardized language, helping laboratories perform more efficiently and successfully.

Integration puts all the pieces together – laboratory tests, imaging studies, medical histories and doctors’ reports – so that a complete picture of each patient is readily available and easily understood.

Performed on blood, tissue or other patient samples, in vitro diagnostics are a critical source of objective information for improved disease management and patient care.

In modern healthcare, in vitro diagnostics go far beyond simply telling a doctor whether a patient has a certain disease or not. Today, they are an integral part of decision-making along the entire continuum of a patient’s health or disease, enabling physicians to make full use of IVDs along the healthcare value chain.

In vitro diagnostics (IVDs) have long been considered the “silent champion” of healthcare, influencing over 60 % of clinical decision-making, while accounting for only about 2% of total healthcare spending.

Diagnostics allows laboratories to be the reliable partners that healthcare professionals need. It empowers doctors to make the right decisions for their patients at the right time; it allows people to have improved control over their health and wellbeing; and it gives payers and policymakers the confidence that they are investing in the right solutions for patients and the future of healthcare.

Modern diagnostics reduces costs by diminishing subsequent health problems, reducing hospitalisation and avoiding unnecessary treatment. The future of sustainable healthcare depends on diagnostics.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

MOHAP license number: S2HYWH3F-070823

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAdverse event reportingAbout RocheFocus areasRoche careersMediaPrivacy policyTerms & ConditionsLegal statementPrivacy Notice for Roche Virtual Meetings